INTENSITY THERAPEUTICS, INC.
Develops injected therapies to kill tumors locally and activate a systemic immune response.
INTS | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1 ENTERPRISE DRIVE, SUITE 430, 6484 SHELTON
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company developing a novel, immune-based approach to treat solid tumor cancers. The company's proprietary DfuseRx℠ technology platform enables the direct intratumoral injection of therapeutic agents. This 'treat locally, act globally' method is designed to kill cancer cells within the injected tumor while simultaneously activating a systemic, antigen-specific immune response to attack metastatic sites throughout the body. Its lead product candidate, INT230-6, is being evaluated in clinical trials for various cancers, including breast cancer and sarcomas. The company's mission is to extend patient survival and improve quality of life while preventing disease recurrence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INTENSITY THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INTENSITY THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INTENSITY THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
